Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0646
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response ; volume:28 ; number:3 ; day:16 ; month:9 ; year:2009 ; pages:326-333 ; date:6.2010
Investigational new drugs ; 28, Heft 3 (16.9.2009), 326-333, 6.2010
- Creator
-
Ma, Brigette B.Y
Lui, Vivian W.Y
Poon, Fan Fong
Wong, S.C. Cesar
To, Ka Fai
Wong, Elaine
Chen, Honglin
Lo, Kwok Wai
Tao, Qian
Chan, Anthony T.C
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10637-009-9316-7
- URN
-
urn:nbn:de:101:1-2019072821171852205430
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ma, Brigette B.Y
- Lui, Vivian W.Y
- Poon, Fan Fong
- Wong, S.C. Cesar
- To, Ka Fai
- Wong, Elaine
- Chen, Honglin
- Lo, Kwok Wai
- Tao, Qian
- Chan, Anthony T.C
- SpringerLink (Online service)
Other Objects (12)
Erratum to: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Clinical and Preclinical Experience with Gefitinib and Sunitinib
MiRNA-125a-5p: a regulator and predictor of gefitinib’s effect on nasopharyngeal carcinoma
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
A New Synthesis of Gefitinib
Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation
Evaluation of novel Epstein-Barr virus serological biomarkers for nasopharyngeal carcinoma
Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance
Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma
Erratum to: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Clinical and Preclinical Experience with Gefitinib and Sunitinib
MiRNA-125a-5p: a regulator and predictor of gefitinib’s effect on nasopharyngeal carcinoma
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
A New Synthesis of Gefitinib
Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation
Evaluation of novel Epstein-Barr virus serological biomarkers for nasopharyngeal carcinoma
Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance
Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma
Erratum to: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Clinical and Preclinical Experience with Gefitinib and Sunitinib
MiRNA-125a-5p: a regulator and predictor of gefitinib’s effect on nasopharyngeal carcinoma
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
A New Synthesis of Gefitinib
Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation
Evaluation of novel Epstein-Barr virus serological biomarkers for nasopharyngeal carcinoma
Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance
Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer